Key requirements for this role include a demonstrated capability to model antibody drug conjugate kinetics and mechanisms, experience with drug linker and drug substance process design, development of flow chemistry reactor platforms, including in use for ADC's, experience with highly potent compound handling, leadership of novel reactor configuration development (e.g., photochemistry, electrochemistry, membrane reactors, etc.), and expertise in computational fluid dynamics to support reactor design and tech transfer. R&D Process Engineering, a part of AbbVie's Development Sciences organization in Synthetic Molecules CMC (Chemistry, Manufacturing, and Controls), is responsible for designing and developing scalable processes to make drug substances and drug products, including small molecules and antibody drug conjugates (ADCs), throughout pre-clinical and clinical development stages.